“…Due to the toxic effects presented by organic solvents, ethanol and dimethyl sulfoxide (DMSO) [ 18 , 19 ], a variety of nanostructured systems for controlled release have been developed to improve the bioavailability, solubility and therapeutic efficacy of CUR [ 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ]. Nanosystems have been developed to circumvent CUR solubility, such as polymeric nanoparticles, inorganic nanoparticles and liposomes; however, micelles have several advantages such as the ability to incorporate lipo and water-soluble drugs, low cost and ease of large-scale production [ 31 , 32 , 33 , 34 , 35 , 36 ].…”